Pfizer (PFE) enters into an agreement with AstraZeneca (AZN) for the over-the-counter rights for...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE) enters into an agreement with AstraZeneca (AZN) for the over-the-counter rights for Nexium. As a consequence, it guides FY12 EPS lower, now expecting to earn $2.12 - $2.22, versus previous estimates of $2.14 - $2.24. R&D expenses now expected to be $6.75B to $7.25B, higher than previous $6.5B - $7B estimate.